BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Bausch Health Announces 2023 Annual Meeting of Shareholder Results

  Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the results of its 2023 annual meeting of shareholders.

  May 17, 2023

   · 

  3 min read
• BioMidwest

  The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors

  The National Marrow Donor Program® /Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving the way to successful cell therapy clinical trials with a comprehensive approach and patient support,” to mark Clinical Trials Day 2023.

  May 17, 2023

   · 

  6 min read
• Biotech Bay

  Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling

  Guardant Health, Inc., a leading precision oncology company, announced that it has received new commercial health plan coverage for the Guardant360 liquid biopsy test from Anthem Blue Cross and Blue Shield, Aetna and Humana.

  May 17, 2023

   · 

  5 min read
• IPA to Present at Jefferies Healthcare Conference 2023

  ImmunoPrecise Antibodies Ltd. today announced that Dr. Jennifer Bath, the company’s Chief Executive Officer and President, will present at the Jefferies Healthcare Conference on Friday June 9, 2023, at 11:00 a.m. Eastern time.

  May 17, 2023

   · 

  1 min read
• Business

  Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission

  Motus GI Holdings, Inc. today announced in collaboration with the Ecuadorian Institute of Digestive Diseases (IECED) initiation of a clinical evaluation of the Pure-Vu Gen 4 Gastro, which is designed for upper gastrointestinal (GI) bleeding procedures - an area of high unmet patient need.

  May 17, 2023

   · 

  6 min read
• FDA

  Sientra Announces FDA-Clearance of Novel Portfinder™ Technology

  Sientra, Inc. announced that the Food and Drug Administration (FDA) has granted a 510(k) clearance for the Company’s novel Portfinder™ technology.

  May 17, 2023

   · 

  5 min read
• Business

  Eterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting

  Eterna Therapeutics Inc. and Factor Bioscience will present eight poster presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting, taking place May 16-20, 2023 at the Los Angeles Convention Center.

  May 17, 2023

   · 

  9 min read
• InMode to Present at Upcoming Investor Conferences and Events

  InMode Ltd. today announced that InMode will participate at the following investor conferences and events.

  May 17, 2023

   · 

  1 min read
• Business

  Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer

  Coeptis Therapeutics Holdings, Inc. announced today the appointment of Brian Cogley, MBA, to the position of Chief Financial Officer (CFO) effective immediately.

  May 17, 2023

   · 

  7 min read
• Business

  Verismo Therapeutics Welcomes Sara Weiss as Senior Vice President of Clinical Operations

  Verismo Therapeutics today announced that Sara Weiss has joined the company as Senior Vice President of Clinical Operations.

  May 17, 2023

   · 

  3 min read